Ivana Bratic Hench
Overview
Explore the profile of Ivana Bratic Hench including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hench J, Hultschig C, Brugger J, Mariani L, Guzman R, Soleman J, et al.
Acta Neuropathol Commun
. 2024 Apr;
12(1):51.
PMID: 38576030
DNA methylation analysis based on supervised machine learning algorithms with static reference data, allowing diagnostic tumour typing with unprecedented precision, has quickly become a new standard of care. Whereas genome-wide...
2.
Hench I, Roma L, Conticelli F, Bubendorf L, Calgua B, Le Magnen C, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201475
Most men with prostate cancer (PCa), despite potentially curable localized disease at initial diagnosis, progress to metastatic disease. Despite numerous treatment options, choosing the optimal treatment for individual patients remains...
3.
Kuschel L, Hench J, Frank S, Hench I, Girard E, Blanluet M, et al.
Neuropathol Appl Neurobiol
. 2022 Oct;
49(1):e12856.
PMID: 36269599
Background: DNA methylation-based classification of cancer provides a comprehensive molecular approach to diagnose tumours. In fact, DNA methylation profiling of human brain tumours already profoundly impacts clinical neuro-oncology. However, current...
4.
Brune M, Vela V, Hench I, Dertinger S, Borgmann V, Dirnhofer S, et al.
Virchows Arch
. 2022 Jun;
481(3):489-497.
PMID: 35661922
Approximately 15% of follicular lymphomas (FL) lack overexpression of BCL2 and the underlying translocation t(14;18). These cases can be diagnostically challenging, especially regarding follicular hyperplasia (FH). In a subset of...
5.
Konig D, Hench J, Frank S, Dima L, Hench I, Laubli H
Pharmacology
. 2022 May;
107(7-8):433-438.
PMID: 35526519
High-grade glioma (HGG) and glioblastoma are the most common adult malignant brain tumors. The standard treatment consists of surgical resection followed by radiochemotherapy with temozolomide. The prognosis and the therapeutic...
6.
Hench I, Della Monica R, Chiariotti L, Bihl M, Tolnay M, Frank S, et al.
Neurooncol Adv
. 2021 Feb;
3(1):vdaa170.
PMID: 33532726
No abstract available.
7.
Alborelli I, Hench I, Chijioke O, Savic Prince S, Bubendorf L, Leuenberger L, et al.
Lung Cancer
. 2020 Sep;
149:84-89.
PMID: 32980613
Objectives: Tumor mutational burden (TMB) has emerged as a promising predictive biomarker for immune checkpoint inhibitor therapy. While the feasibility of TMB analysis on formalin-fixed paraffin-embedded (FFPE) samples has been...
8.
Saleh C, Jaszczuk P, Hund-Georgiadis M, Frank S, Cordier D, Hench I, et al.
Clin Neuropathol
. 2020 Sep;
40(1):17-24.
PMID: 32870144
Methylation profiling has become a mainstay in brain tumor diagnostics since the introduction of the first publicly available classification tool by the German Cancer Research Center in 2017. We demonstrate...
9.
Hench J, Jermann P, Hench I, Matter M
Ther Umsch
. 2019 Sep;
76(4):173-178.
PMID: 31498035
Current methods in molecular pathology Macroscopy and microscopy were the cornerstones of tumor analysis in pathology for many years. Recently, we have witnessed an enormous increase in knowledge of genetic...
10.
Hench I, Cathomas R, Costa L, Fischer N, Gillessen S, Hench J, et al.
Cancers (Basel)
. 2019 Aug;
11(8).
PMID: 31374981
Despite several treatment options and an initial high response rate to androgen deprivation therapy, the majority of prostate cancers will eventually become castration-resistant in the metastatic stage (mCRPC). Androgen receptor...